Company
Finch Therapeutics Group, Inc. (FNCH)
Standardized SEC financial data for Finch Therapeutics Group, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001733257 · OTC · Biological Products, (No Diagnostic Substances).
Revenue growth (YoY)
-87.6%
Return on equity
-326.6%
Free cash flow
-$31.5M
Debt / equity
0.00×
Current ratio
6.33×
EPS (diluted)
$-46.59
Ratios for fiscal year 2023, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|
| Revenue | $7.7M | $18.5M | $861K | $107K |
| R&D expense | $33.1M | $57.3M | $52.9M | $7.2M |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Cash & equivalents | — | $99.7M | $133.5M | $73.8M | $27.5M |
| Total current assets | — | $106.2M |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|
| Operating cash flow | -$31.3M | -$67.1M | -$74.9M | -$31.5M |
| Capital expenditures | — | $16.0M | $2.2M | $0 |
Get FNCH data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/FNCH/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/FNCH/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"